Why the Administration Wants Limits on Courts Vacating Agency Rules

The Trump administration asked the Supreme Court on October 14 to consider when federal courts may set aside an agency action or rule in its entirety. The request arose from litigation over regulations implementing the No Surprises Act, but the administration framed it as a broader question about judicial authority. SCOTUSblog’s October 16 report described a petition urging the justices to limit remedies that erase a regulation beyond the parties who brought the lawsuit.

The immediate development is a request for Supreme Court review, not a ruling that changes the powers of lower courts. Solicitor General D. John Sauer argued that the governing federal administrative law does not authorize the far-reaching remedy challenged by the government. That is the administration’s legal position. Whether the justices will take the case, and whether they would accept that interpretation if they do, are distinct questions from the filing itself.

How a Medical Billing Dispute Reached This Point

The litigation began with challenges to rules issued by the departments of Health and Human Services, Labor and the Treasury to implement parts of the No Surprises Act. SCOTUSblog described the statute as intended to protect patients from unexpected medical bills, particularly involving emergencies or out-of-network providers. The challengers included the Texas Medical Association, a hospital and four air ambulance companies. The present petition concerns the remedy following those regulatory challenges, rather than a request to repeal the underlying statute.

A federal district court in Texas ruled for the challengers. A three-judge panel of the U.S. Court of Appeals for the Fifth Circuit reversed in part, and the full appeals court later vacated some challenged provisions, according to the report. An opinion joined by nine judges rejected the government’s argument that vacatur would produce practical problems, including possible gaps in patient protections while regulations were rewritten. That concern was an argument in the litigation, not a finding that every protection had disappeared.

Vacatur and Nationwide Injunctions

Vacatur, as the administration describes the disputed remedy, removes the challenged regulations as to everyone rather than only preventing enforcement against the plaintiffs. The petition draws a comparison with Trump v. CASA, the Supreme Court’s 2025 decision concerning universal injunctions. SCOTUSblog reported that CASA rejected such injunctions, which prohibit enforcement of a policy nationwide. The administration argues that the reasoning about relief extending beyond the parties should also constrain the setting aside of agency rules.

The comparison does not mean the two remedies have already been held legally identical. The administration is asking the court to carry reasoning from one setting into another. Sauer argued that courts traditionally provide complete relief to the parties before them without generally extending beyond those parties. He contended that nationwide vacatur instead allows a small group of challengers to remove regulations for everyone. Whether the relevant administrative statute permits that result is the question the petition seeks to place before the justices.

Sauer also argued that broad vacatur encourages forum shopping and creates pressure for emergency Supreme Court review. According to SCOTUSblog, the petition said nationwide effects can force the government to seek urgent relief and require courts to decide difficult legal issues on accelerated schedules. These are asserted consequences supporting the administration’s proposed limit. They should not be read as independent findings that every challenge to an agency rule produces those problems.

The dispute therefore separates two questions that are easily conflated: whether an agency regulation is lawful and how widely a court’s remedy should operate after finding a problem. The original medical billing litigation supplied the setting for that distinction. A decision on the scope of relief would not, merely by addressing that scope, amount to a general judicial judgment about whether surprise-billing protections are desirable public policy.

As reported October 16, the challengers’ response was due November 13, with the possibility of an extension. SCOTUSblog’s case page identifies the proceeding as Department of Health and Human Services v. Texas Medical Association. The petition establishes a new attempt to obtain Supreme Court guidance on the reach of judicial remedies. It does not establish that review has been granted, that nationwide vacatur has been barred or that the challenged regulations have been restored by the Supreme Court.